Document text
Principal Investigator: A.M. Rostami
Organization: THOMAS JEFFERSON UNIVERSITY
Fiscal Year: 2024
Award: $390,000
Funding agency: National Institute of Allergy and Infectious Diseases
SUMMARY ThGM Cells in CNS Autoimmunity
ThGM cells (ThGM-CSF) are a newly described Th subset characterized by production of GM-CSF, but
lacking expression of signature cytokines and master transcription factors (TF) for established Th cell
lineages. In our analysis, ThGM cells were notably more abundant than Th2 and Th17 cells in the blood of
healthy subjects, and even more so in MS patients. Although ThGM cells have some features of a distinct
lineage, further study is needed to clarify that distinction, as well as their roles in health and disease. ThGM cells
were highly encephalitogenic in the adoptive EAE model, and they can be readily found in the CNS of mice
with direct EAE. Importantly, ThGM cells were enriched in the cerebrospinal fluid of MS patients, who also
have greater numbers of circulating ThGM cells than healthy individuals. These findings suggest that ThGM
cells contribute to the pathogenesis of CNS autoimmunity, but this subject has been only minimally studied. Over
all, our data and published findings led us to hypothesize that ThGM cells play a significant pathogenic role
in autoimmune neuroinflammation, MS and EAE. We will test this hypothesis in the following specific aims:
Aim 1. To determine the origin of ThGM cells, and characterize the relationship between their GM-CSF
expression and phenotype. Both human and mouse ThGM cells can be readily differentiated directly from
naïve CD4+ T cells in vitro; however, it is unclear if ThGM cells in vivo originate from naïve precursors, or a
Th lineage that switched its phenotype. We hypothesize that ThGM cells in vivo develop directly from naïve
CD4+ T cells. In addition, we will study whether GM-CSF is a key determinant of ThGM cell phenotype, or
these cells have a unique overall phenotype irrespective of GM-CSF expression.
Aim 2. To study the role of ThGM cells in autoimmune neuroinflammation. Recent findings have
suggested that ThGM cells contribute to CNS autoimmunity, as they are overrepresented in MS patients’
PBMCs, and they induce EAE in mice by passive transfer. This led us to hypothesize that ThGM cells play
a significant pathogenic role in MS and EAE. In mice, we will characterize CNS autoimmunity induced by
ThGM cells, while in the human system we will test their pathogenicity in organotypic brain slices, and
characterize ThGM cells in MS brain lesions.
Aim 3. To determine the role of candidate TFs in shaping ThGM phenotype. ThGM cells do not express
master TFs of established Th lineages, suggesting that the ThGM phenotype is shaped by TF(s) differentially
expressed in ThGM cells. Our findings form the basis for the hypothesis that the ThGM phenotype is directed
by a set of TFs naturally overexpressed in ThGM cells compared to other Th cells. We will test this hypothesis
using mice lacking candidate TFs and by knocking down expression of candidate TFs in human CD4+ T cells.
Knowledge gained from these studies may modify the current concept of CNS autoimmunity.
Terms: <(TNF)-α><APT1LG1><Address><Autoimmune><Autoimmune Diseases><Autoimmune Status><Autoimmunity><Basal Transcription Factor><Basal transcription factor genes><Binding><Biology><Blood><Blood Reticuloendothelial System><Brain><Brain Nervous System><CCL20><CCL20 gene><CD178><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CD95L><CNS autoimmunity><Cachectin><Cell Body><Cell Lineage><Cell Shape><Cell secretion><Cells><Cellular Secretion><Cellular biology><Cerebrospinal Fluid><Chemokine, CC Motif, Ligand 20><Classification><Co-Stimulator><Complex><Costimulator><Data><Development><Disease><Disorder><Disseminated Sclerosis><EAE><Encephalon><Epidermal Thymocyte Activating Factor><Exodus 1><Experimental Allergic Encephalitis><Experimental Allergic Encephalomyelitis><Experimental Autoimmune Encephalitis><Experimental Autoimmune Encephalomyelitis><Expression Signature><FASL><Future><GM-CSF><Gene Expression Profile><General Transcription Factor Gene><General Transcription Factors><Granulocyte-Macrophage Colony-Stimulating Factor><Health><Histamine-Producing Cell-Stimulating Factor><Human><IL-2><IL2 Protein><Immune><Immunes><Immunity><In Vitro><Individual><Inflammation><Interleukin 2><Interleukin 2 Precursor><Interleukin II><Interleukin-2><Interleukine 2><Interleukine 2 Precursor><Interleukine II><KO mice><Knock-out Mice><Knockout Mice><Knowledge><LARC><Lesion><Lymphocyte Mitogenic Factor><MIP3A><MS Lesions><MS patient><MS treatment><Macrophage Inflammatory Protein 3-Alpha><Macrophage-Derived TNF><Mediator><Membrane><Mice><Mice Mammals><Mitogenic Factor><Modeling><Modern Man><Molecular Interaction><Molgramostin><Monocyte-Derived TNF><Multiple Sclerosis><Multiple Sclerosis Lesions><Murine><Mus><Myeloid Cells><Names><Nature><Null Mouse><PBMC><Pathogenesis><Pathogenicity><Peripheral Blood Mononuclear Cell><Phenotype><Physiologic><Physiological><Play><Population><Process><Production><Proteome><Publishing><Role><SCYA20><Shapes><Slice><Small Inducible Cytokine Subfamily A, Member 20><System><Systematics><T cell growth factor><T-Cell Growth Factor><T-Cell Stimulating Factor><T-Cells><T-Lymphocyte><T4 Cells><T4 Lymphocytes><TC-GM-CSF><TNF><TNF A><TNF Alpha><TNF gene><TNF-α><TNFA><TNFSF6><TNFSF6 gene><TNFα><Testing><Thymocyte Stimulating Factor><Transcription Factor Proto-Oncogene><Transcription factor genes><Tumor Necrosis Factor><Tumor Necrosis Factor-alpha><Tumor-Cell Human GM Colony-Stimulating Factor><autoimmune condition><autoimmune disorder><autoimmune encephalomyelitis><autoimmunity disease><cell biology><central nervous system autoimmunity><cerebral spinal fluid><cytokine><developmental><differential expression><differentially expressed><gene expression pattern><gene expression signature><global gene expression><global transcription profile><granulocyte macrophage colony stimulating factor><immune system function><in vivo><insular sclerosis><knock-down><knockdown><membrane structure><multiple sclerosis patient><multiple sclerosis therapy><multiple sclerosis treatment><name><named><naming><neural inflammation><neuroinflammation><neuroinflammatory><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapeutics><new therapy><new therapy approaches><new treatment approach><new treatment strategy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapeutics><novel therapy><novel therapy approach><overexpress><overexpression><patients with MS><patients with multiple sclerosis><people with Multiple sclerosis><scRNA-seq><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><spinal fluid><thymus derived lymphocyte><transcription factor><transcriptional differences><transcriptional profile><transcriptional signature><transcriptome>